Pioneering CAR-T Cell Therapy: Advancing Personalized Cancer Treatment | CUSABIO скачать в хорошем качестве

Pioneering CAR-T Cell Therapy: Advancing Personalized Cancer Treatment | CUSABIO

In this webinar, we discussed the research progress in cell therapy, with a focus on ongoing studies exploring both the benefits and limitations of expanding CAR-T therapy. This promising development marks a pivotal shift toward more targeted and effective treatments, positioning CAR-T cell therapy as a powerful ally in the fight against cancer and other diseases. Cell therapy, a rapidly evolving branch of regenerative medicine, holds the potential to revolutionize the way we treat a variety of diseases, particularly in the field of oncology. Among the most promising developments within this field is Chimeric Antigen Receptor T-cell (CAR-T) therapy, which leverages the body's own immune system to target and destroy cancer cells. This innovative treatment involves the genetic modification of a patient's own T-cells to enhance their ability to target and eliminate cancer cells. In CAR-T therapy, T-cells are extracted from the patient's blood and then engineered in a laboratory to express chimeric antigen receptors (CARs). These CARs are designed to bind to specific antigens present on the surface of cancer cells. Once the T-cells have been modified and multiplied, they are reintroduced into the patient’s body via infusion. Upon reinfusion, these modified T-cells, now armed with CARs, can seek out and eliminate cancer cells with heightened specificity and efficiency. This personalized immunotherapy not only enhances the body's natural defenses against cancer but also offers renewed hope for patients who have exhausted conventional treatment options.